Global Lurasidone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Lurasidone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
Lurasidone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lurasidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Psychological Clinic are the major drivers for the industry.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lurasidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co., Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
Segment by Type
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Hospital
Psychological Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lurasidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lurasidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lurasidone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lurasidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lurasidone introduction, etc. Lurasidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lurasidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Lurasidone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lurasidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Psychological Clinic are the major drivers for the industry.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lurasidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co., Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
Segment by Type
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Segment by Application
Hospital
Psychological Clinic
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lurasidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lurasidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lurasidone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lurasidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lurasidone introduction, etc. Lurasidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lurasidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices